Watchlist Price Alert

Abbott Laboratories (ABT)

NYSE: ABT · Real-Time Price · USD

134.69

1.02 (0.76%)

At close: Jun 27, 2025, 12:21 PM

Abbott Laboratories Balance Sheet Statement

Financials in USD. Fiscal year is January - December.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	Dec 31, 2018	Dec 31, 2017	Dec 31, 2016
Cash & Equivalents	7.62B	6.9B	9.88B	9.8B	6.84B	3.86B	3.84B	9.41B	18.62B
Short-Term Investments	351M	383M	288M	450M	310M	280M	242M	203M	155M
Long-Term Investments	886M	799M	766M	816M	821M	883M	897M	883M	2.95B
Other Long-Term Assets	16.46B	5.97B	n/a	n/a	n/a	n/a	17M	176M	2.75B
Receivables	6.92B	6.57B	6.22B	6.49B	6.41B	5.42B	5.18B	5.25B	3.25B
Inventory	6.19B	6.57B	6.17B	5.16B	5.01B	4.32B	3.8B	3.6B	2.43B
Other Current Assets	n/a	169M	2.66B	n/a	n/a	n/a	n/a	158M	789M
Total Current Assets	23.66B	22.67B	25.22B	24.24B	20.44B	15.67B	14.63B	20.15B	26.78B
Property-Plant & Equipment	10.66B	11.28B	9.16B	8.96B	9.03B	8.04B	7.56B	7.61B	5.71B
Goodwill & Intangibles	29.75B	32.49B	33.25B	35.97B	38.53B	40.22B	42.2B	45.49B	12.22B
Total Long-Term Assets	57.76B	50.54B	49.21B	50.96B	52.11B	52.22B	52.54B	56.1B	25.89B
Total Assets	81.41B	73.21B	74.44B	75.2B	72.55B	67.89B	67.17B	76.25B	52.67B
Account Payables	4.2B	4.29B	4.61B	4.41B	3.95B	3.25B	2.98B	2.4B	1.18B
Deferred Revenue	n/a	174M	n/a	n/a	n/a	n/a	305M	309M	188M
Short-Term Debt	1.5B	1.08B	2.25B	754M	220M	1.48B	207M	714M	1.32B
Other Current Liabilities	6.22B	1.19B	1.29B	950M	873M	642M	729M	922M	3.22B
Total Current Liabilities	14.16B	13.84B	15.49B	13.11B	11.91B	10.86B	9.01B	8.91B	6.66B
Long-Term Debt	12.63B	13.6B	14.52B	17.3B	18.53B	16.66B	19.36B	27.21B	20.68B
Other Long-Term Liabilities	5.32B	6B	4.74B	5.74B	6.06B	6.18B	6.02B	7.02B	4.25B
Total Long-Term Liabilities	19.36B	20.55B	22.04B	26.07B	27.64B	25.72B	27.44B	36.24B	25.29B
Total Liabilities	33.51B	34.39B	37.53B	39.17B	39.55B	36.59B	36.45B	45.15B	31.95B
Total Debt	15.02B	15.87B	17.72B	19.01B	19.65B	18.89B	19.57B	27.92B	22.01B
Common Stock	25.15B	24.87B	24.71B	24.47B	24.14B	23.85B	23.51B	23.21B	13.03B
Retained Earnings	47.26B	37.55B	35.26B	31.53B	27.63B	25.85B	24.56B	23.98B	25.57B
Comprehensive Income	-7.91B	-7.84B	-8.05B	-8.37B	-8.95B	-8.46B	-7.59B	-6.06B	-7.26B
Shareholders Equity	47.66B	38.6B	36.69B	35.8B	32.78B	31.09B	30.52B	30.9B	20.54B
Total Investments	1.24B	1.18B	1.05B	1.27B	1.13B	1.16B	1.14B	1.09B	3.1B